Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00902278 · ClinicalTrials.gov registry record · NA
Immune Responses Induced by Different Licensed Influenza Vaccines
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
NCT00902278: Completed NA study, sponsored by University of Massachusetts, Worcester.
NCT00902278 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 193 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00902278, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
Study Summary
The goal of this research is to find out how the body's immune system responds to different manufacturer's "flu" vaccines.
Primary Outcome
Comparison of mean peak fold increases in ELISPOT H1N1, H3N2, and B responses between different vaccine groups
Interventions
- BIOLOGICAL Fluzone
- BIOLOGICAL Afluria
- BIOLOGICAL Fluarix
- BIOLOGICAL Fluvirin
- BIOLOGICAL Flulaval
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2008-10 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT00902278 record still lists
NCT00902278 is an interventional study that assigns participants to a tested intervention. The registered 193 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 5 interventions - of which Fluzone is the first listed.
NCT00902278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00902278 about?
NCT00902278 is a clinical study titled "Immune Responses Induced by Different Licensed Influenza Vaccines". The goal of this research is to find out how the body's immune system responds to different manufacturer's "flu" vaccines.
What is the current status of trial NCT00902278?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2008-10. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00902278?
The interventions under investigation include: Fluzone (BIOLOGICAL), Afluria (BIOLOGICAL), Fluarix (BIOLOGICAL), Fluvirin (BIOLOGICAL), Flulaval (BIOLOGICAL).
Who is sponsoring clinical trial NCT00902278?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00902278's enrollment target sits among peer trials
193 569th of 2000 higher than 1,431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06226220 · 193 participants · NA
Percutaneous Nerve Evaluation Trial Time
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia